Oral Estradiol Valerate |
2 to 8 mg per day |
Estradiol levels can be monitored, Risk of VTE is slightly less than with Ethinyl Estradiol or Conjugated Equine Estrogen |
High risk of VTE |
Oral 17-beta Estradiol |
1-6 mg daily |
Inexpensive and estradiol levels can be monitored |
High risk of VTE specially in older patients (>40 yrs ) |
Oral Ethinyl Estradiol |
50-100 ug per day |
Inexpensive |
Cannot be monitored by measurement of serum levels and high risk of VTE |
Conjugated Equine Estrogen |
1.25 to 5 mg per day |
Widely available |
Cannot be monitored by measurement of serum levels, high risk of VTE, expensive and contains impurities |
Parenteral Estradiol Valerate |
10-20 mg IM every 1-2 week |
Estradiol levels can be monitored, Risk of VTE is slightly less than with Ethinyl Estradiol or Conjugated Equine Estrogen |
Injectable preparation |
Transdermal 17-beta Estradiol gel (0.06%) for application |
1.25 gm gel per day (0.75 mg estradiol) to 5 gm gel per day (3 mg estradiol) (Application in the arms or in the upper half of the body) |
Low risk of venous thromboembolism |
Not easily available in India May not be successful in a tropical country like India |